System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Gerd U Auffarth is an expert in Ophthalmology at University Hospital Heidelberg (Germany). As of October 2026, ScienceLeadR ranks Gerd U Auffarth in the top 1% of experts worldwide for Lens Diseases, Cataract and Visual Acuity. Gerd U Auffarth has authored 671 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 2,048 (community average: 125). How the SLR is computed.

LeadR Profile

Gerd U Auffarth University Hospital Heidelberg Germany
2 048 ScienceLeadR Reputation 2048

Unlock

Register Login
Network Map

Ophthalmology

Subspecialties: Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026
Source: PubMed

University Hospital Heidelberg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 671

Citations

Citations: 10 117 1st author: 72 Last author: 208 Unique author: 11

Main journals

Klin Monbl Augenheilkd 78
Ophthalmologe 78
J Cataract Refract Surg 72
J Refract Surg 47
Ophthalmologie 38

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Protection of Bevacizumab From Silicone Oil-Induced Inactivation by Liposomal Encapsulation.
PMID 42895282 — endotamponade, pharmaceutical preparations, silicone oils, liposomes, bevacizumab, signs and symptoms, silicones		Transl Vis Sci Technol20260
Time-, Location-, and Layer-Specific Chorioretinal Biomarkers in a Translational Large-Animal Porcine Model of Chorioretinal Ischemia.
PMID 42831588 — retinal artery, ophthalmology, retina, biomarkers, heart arrest, tomography, optical coherence, retinaldehyde, ischemia		Invest Ophthalmol Vis Sci20260
[Case series: anterior and posterior manifestations of scleritis].
PMID 42830362 — ophthalmology, scleritis, therapeutics		Ophthalmologie20260
Visual and refractive evaluation of two diffractive trifocal intraocular lens platforms with distant and near dominant light energy distributions.
PMID 42761690 — eye, lenses, intraocular, multifocal intraocular lenses		Int J Ophthalmol20260
12-Month Visual and Clinical Outcomes After Implantation of a Monofocal Aspheric Hydrophobic Acrylic IOL: A Prospective Feasibility Study.
PMID 42725124 — eye, feasibility studies, lenses, intraocular, visual acuity		Clin Ophthalmol20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 6
Phase 3 3
Phase 4 2

By status:

Completed 6
Recruiting 2
Terminated 2
Unknown 1

By type:

Interventional 10
Observational 1

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 2
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Investigation for Assessing the Visual Performance of Hanita Lenses Intensity SL IOL in Comparison to Alcon Panoptix IOL
NCT06084169 — eye, research design, lenses, cataract, men		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS